Cite
HARVARD Citation
Lim-Fat, M. et al. (2022). Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making. Neuro-oncology. 24 (7), pp. 1140-1149. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lim-Fat, M. et al. (2022). Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making. Neuro-oncology. 24 (7), pp. 1140-1149. [Online].